These findings are consistent with those reported by Eiber et al. [18], who demonstrated that PSMA-PET/mpMRI improves the accuracy for intraprostatic tumour localization compared to mpMRI and PSMA-PET alone, correctly identifying lesions in 98% of cases versus 66% for mpMRI and 92% for PSMA-PET. This evidence concerns the gene FOLH1 and neoplasm.